29 November 2019
AfriAg Global
PLC
(‘AfriAg’ or the
‘Company’)
Disposal of
African business and Total Voting Rights
AfriAg Global PLC (London NEX: AFRI) is pleased to announce that
further to its General Meeting held on 27
November 2019 at which meeting shareholder approval was
granted to proceed with the disposal of its subsidiaries, which
operates its African operations (the “Disposal”), it has
completed the Disposal. Following completion of the Disposal the
Company holds no interest in any subsidiary company save for its
investments in Apollon Formularies Limited and Tilray, Inc.
Total Voting Rights
In accordance with the Financial Conduct Authority's Disclosure
and Transparency Rules, the Company hereby announces that it has
31,710,011 ordinary shares of no par value each in issue, each
share carrying the right to one vote.
This figure of 31,710,011 ordinary shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change in their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency Rules.
The directors of the Company accept responsibility for the
contents of this announcement.
-ENDS-
For further information on AfriAg Global please visit the
www.afriagglobal.com or please contact;
AfriAg Global Plc:
David Lenigas (Executive
Chairman)
+44 (0)20 7440 0640
Peterhouse Capital
Limited +44
(0)20 7469 0930
Guy Miller/ Allie Feuerlein
